sglt2 glp 1 GLP-1 receptor agonists and inhibitors: a couple at last? Perspectives in weight control in

GLP-1 Dementia, Alzheimers Disease Risks Questioned in New Study Researchers suggested the increased risks may be linked to GLP-1 patients living longer, while cautioning that additional clinical trials are needed to better understand any link between GLP-1s and dementia

A denial is not the end of the process

Specifically, L

Accurate dosage and administration are vital for achieving the best therapeutic outcomes and minimizing the risk of hypersensitivity reactions

In support of fatty acid synthase (FAS) as a metabolic oncogene: Extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells

Furthermore, homocysteine-induced apoptosis is mainly mediated by induction DNA injury and energy depletion (Fan et al